Author: Mackenzie Bean

New York City-based Mount Sinai Health System has tapped Joseph Sparano, MD, as chief of hematology and medical oncology.

A small survey shows oncologists may often underestimate their patients' use of complementary medicines, Medscape reported June 14. 

Maria Fardis has submitted her resignation as president, CEO and director of the immune-oncology company Iovance Biotherapeutics, reports the San Francisco Business Times.

A growing number of oncologists are voicing concerns about the indirect costs of cancer care — such as parking fees — that contribute to patients' financial burden, reports Kaiser Health News.

Dana-Farber Cancer Institute received a $50 million gift to support pancreatic cancer research, the Boston-based organization said May 11.

ChristianaCare's cancer center has created a program to provide long-term care and support to childhood cancer survivors, the Wilmington, Del.-based health system said April 14.

New Brunswick-based Rutgers Cancer Institute of New Jersey has appointed Michael Salacz, MD, as director of its neuro-oncology program, the institute said March 24.

There is no denying COVID-19 has transformed much of our world, perhaps permanently. But exactly what that means for future cancer patients and providers is yet to be seen.

President Joe Biden is urging Americans to stay vigilant against cancer and not avoid any necessary screenings or treatments.

The Dartmouth-Hitchcock Norris Cotton Cancer Center in Lebanon, N.H., has installed radiation vision cameras in its radiotherapy treatment rooms, allowing clinicians to see real-time video of the radiation treatment beam as it's directed on patients via a process known as…